FBIONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as FBIOP
Fortress Biotech, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.87+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $59.45M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
17.5%
6M of 33M shares
Institutional holders
55
13 new, 10 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Lindsay A. Rosenwald, M.D. | 6,917,715 | 20.70% | 13D (active) amendment | Mar 18, 2026 |
| Highbridge Capital Management, LLC | 2,734,654 | 7.80% | 13G (passive) amendment | Mar 31, 2026 |
| Israel A. Englander | 1,778,561 | 5.30% | 13G (passive) | Aug 26, 2026 |
| Michael S. Weiss | 1,130,520 | 7.60% | 13D (active) amendment | Nov 14, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of FBIO | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 1,037,203 | 3.11% | $3.17M | +71,173 | 0.00% |
| Opaleye Management Inc. | 890,000 | 2.67% | $2.72M | −152,000 | 0.25% |
| Mackenzie Financial Corp | 555,676 | 1.67% | $1.70M | New | 0.00% |
| Gsa Capital Partners Llp | 458,472 | 1.37% | $1.40K | +204,338 | 0.09% |
| Shikiar Asset Management Inc | 305,469 | 0.92% | $935 | – | 0.24% |
| Geode Capital Management, LLC | 300,521 | 0.90% | $919.94K | +10,266 | 0.00% |
| BlackRock, Inc. | 224,782 | 0.67% | $687.83K | +27,697 | 0.00% |
| Two Sigma Investments, LP | 213,786 | 0.64% | $654.19K | +16,961 | 0.00% |
| Bridgeway Capital Management, LLC | 177,368 | 0.53% | $542.75K | −5,000 | 0.01% |
| Vanguard Fiduciary Trust Co | 166,371 | 0.50% | $509.10K | +23,836 | 0.00% |
| HB Wealth Management, LLC | 116,675 | 0.35% | $357.03K | −3,500 | 0.00% |
| Kestra Advisory Services, LLC | 116,235 | 0.35% | $355.68K | −13,566 | 0.00% |
| Acadian Asset Management LLC | 107,303 | 0.32% | $327 | +66,853 | 0.00% |
| State Street Corp | 101,601 | 0.30% | $310.90K | – | 0.00% |
| Goldman Sachs Group Inc | 96,358 | 0.29% | $294.86K | New | 0.00% |
| Integrated Wealth Concepts LLC | 90,400 | 0.27% | $276.62K | +45,200 | 0.00% |
| Renaissance Technologies LLC | 86,390 | 0.26% | $264.35K | −13,200 | 0.00% |
| Citadel Advisors LLC | 77,065 | 0.23% | $235.82K | −103,224 | 0.00% |
| Integrated Quantitative Investments LLC | 68,692 | 0.21% | $210.20K | New | 0.03% |
| Panagora Asset Management Inc | 66,025 | 0.20% | $202.04K | +9,357 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 55 | 6M | 17.5% | 13 / 13 | 18 / 10 | 1M | 1M |
| Q1 2026 | 52 | 5M | 16.1% | 13 / 11 | 17 / 11 | 2M | 1M |
| Q4 2025 | 52 | 6M | 17.7% | 13 / 16 | 15 / 15 | 2M | 1M |
| Q3 2025 | 56 | 4M | 13.4% | 20 / 16 | 13 / 13 | 1M | 2M |
| Q2 2025 | 49 | 5M | 14.9% | 11 / 16 | 12 / 8 | 2M | 2M |
| Q1 2025 | 46 | 5M | 14.7% | 2 / 19 | 11 / 9 | 1M | 1M |
| Q4 2024 | 53 | 5M | 14.4% | 11 / 22 | 12 / 8 | 1M | 1M |
| Q3 2024 | 50 | 4M | 13.3% | 6 / 22 | 12 / 5 | 1M | 1M |
| Q2 2024 | 50 | 4M | 11.3% | 16 / 15 | 8 / 5 | 1M | 0M |
| Q1 2024 | 39 | 3M | 8.4% | 8 / 12 | 10 / 10 | 1M | 3M |
| Q4 2023 | 42 | 5M | 15.2% | 41 / 0 | 1 / 1 | 5M | 2M |
| Q3 2023 | 2 | 3M | 7.7% | 2 / 0 | 0 / 0 | 3M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of FBIO | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 697,802 | 2.09% | $2.14M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 279,891 | 0.84% | $856.47K | 0.00% | Jun 30, 2026 |
| Ultra-Small Company Fund | 152,368 | 0.46% | $466.25K | 0.47% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 131,019 | 0.39% | $366.85K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 88,143 | 0.26% | $269.72K | 0.02% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 49,359 | 0.15% | $138.21K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 35,874 | 0.11% | $100.45K | 0.00% | May 31, 2026 |
| EA Bridgeway Omni Small-Cap Value ETF | 25,000 | 0.07% | $76.50K | 0.00% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 20,365 | 0.06% | $57.02K | 0.00% | May 31, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 18,051 | 0.05% | $55.24K | 0.00% | Jun 30, 2026 |
| Vanguard Balanced Index Fund | 10,255 | 0.03% | $31.38K | 0.00% | Jun 30, 2026 |
| Nomura Healthcare Fund | 6,666 | 0.02% | $20.40K | 0.00% | Jun 30, 2026 |
| 1290 VT Micro Cap Portfolio | 5,933 | 0.02% | $18.15K | 0.01% | Jun 30, 2026 |
| Total Stock Market Index Trust | 728 | 0.00% | $2.23K | 0.00% | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | 20 | 0.00% | $61 | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Michael S. Weiss | Executive Vice Chairman, Director | 2,276,562 | 6.83% | Mar 20, 2026 |
| Lindsay A. Rosenwald Md | PRESIDENT, CEO & CHAIRMAN, Director, 10% owner | 6,954,507 | 20.85% | Mar 20, 2026 |
| David Jin | Chief Financial Officer | 1,651,571 | 4.95% | Jun 24, 2026 |
| J. Jay Lobell | Director | 192,397 | 0.58% | Jan 5, 2026 |
| Jimmie Harvey | Director | 146,704 | 0.44% | Jan 5, 2026 |
| Dov Klein | Director | 131,905 | 0.40% | Jan 5, 2026 |
| Kevin Lorenz | Director | 101,675 | 0.30% | Jan 5, 2026 |
| Malcolm Hoenlein | Director | 115,747 | 0.35% | Jan 5, 2026 |
| Lucy Lu | Director | 61,273 | 0.18% | Jan 3, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| David Jin Chief Financial Officer | Jun 22, 2026 | Award | +400,000 | – | – | 1,651,571 |
| David Jin Chief Financial Officer | Apr 1, 2026 | Award | +2,967 | $2.18 | $6.47K | 1,251,571 |
| Lindsay A. Rosenwald Md PRESIDENT, CEO & CHAIRMAN, Director, 10% owner | Mar 18, 2026 | Award | +475,424 | – | – | 4,586,841 |
| Michael S. Weiss Executive Vice Chairman, Director | Mar 18, 2026 | Award | +475,424 | – | – | 2,276,562 |
| Jimmie Harvey Director | Jan 1, 2026 | Award | +27,322 | – | – | 146,704 |
| Dov Klein Director | Jan 1, 2026 | Award | +27,322 | – | – | 130,105 |
| J. Jay Lobell Director | Jan 1, 2026 | Award | +27,322 | – | – | 192,397 |
| Malcolm Hoenlein Director | Jan 1, 2026 | Award | +27,322 | – | – | 115,747 |
| Kevin Lorenz Director | Jan 1, 2026 | Award | +27,322 | – | – | 101,009 |
| David Jin Chief Financial Officer | Oct 1, 2025 | Award | +2,711 | $1.31 | $3.55K | 1,248,604 |
| David Jin Chief Financial Officer | Apr 1, 2025 | Award | +5,000 | $1.22 | $6.10K | 1,245,893 |
| Lindsay A. Rosenwald Md PRESIDENT, CEO & CHAIRMAN, Director, 10% owner | Jan 1, 2025 | Award | +454,153 | – | – | 4,111,417 |
| J. Jay Lobell Director | Jan 1, 2025 | Award | +49,383 | – | – | 165,075 |
| Dov Klein Director | Jan 1, 2025 | Award | +49,383 | – | – | 102,783 |
| Malcolm Hoenlein Director | Jan 1, 2025 | Award | +49,383 | – | – | 88,425 |
| Jimmie Harvey Director | Jan 1, 2025 | Award | +49,383 | – | – | 119,382 |
| Michael S. Weiss Executive Vice Chairman, Director | Jan 1, 2025 | Award | +454,153 | – | – | 1,801,138 |
| Kevin Lorenz Director | Jan 1, 2025 | Award | +49,383 | – | – | 73,687 |
| Lucy Lu Director | Jan 1, 2025 | Award | +49,383 | – | – | 61,273 |
| David Jin Chief Financial Officer | Dec 19, 2024 | Award | +1,000,000 | – | – | 1,240,893 |
| David Jin Chief Financial Officer | Oct 1, 2024 | Award | +2,625 | $1.23 | $3.23K | 240,893 |
| Lindsay A. Rosenwald Md PRESIDENT, CEO & CHAIRMAN, Director, 10% owner | Sep 23, 2024 | Buy | +763,359 | $1.84 | $1.40M | 3,657,264 |
| Lindsay A. Rosenwald Md President, CEO & Chairman, Director, 10% owner | Jul 11, 2024 | Buy | +5,000 | $7.48 | $37.40K | 127,500 |
| David Jin Chief Financial Officer | Jul 10, 2024 | Buy | +500 | $7.50 | $3.75K | 500 |
| Lindsay A. Rosenwald Md President, CEO & Chairman, Director, 10% owner | Jul 9, 2024 | Buy | +5,000 | $7.39 | $36.95K | 122,500 |
| Lindsay A. Rosenwald Md President, CEO & Chairman, Director, 10% owner | Jul 8, 2024 | Buy | +5,000 | $7.35 | $36.75K | 117,500 |
| Lindsay A. Rosenwald Md President, CEO & Chairman, Director, 10% owner | Jun 28, 2024 | Buy | +20,000 | $1.64 | $32.80K | 2,893,905 |
| Dov Klein Director | May 20, 2024 | Sale | −10,000 | $1.89 | $18.90K | 53,400 |
| Lindsay A. Rosenwald Md President, CEO & Chairman, Director, 10% owner | May 16, 2024 | Buy | +10,000 | $1.76 | $17.60K | 2,873,905 |
| David Jin Chief Financial Officer | Apr 1, 2024 | Award | +2,352 | $1.70 | $4.00K | 238,268 |
| Lindsay A. Rosenwald Md President, CEO & Chairman, Director, 10% owner | Jan 5, 2024 | Buy | +50,000 | $2.38 | $119.00K | 2,863,905 |
| Lucy Lu Director | Jan 1, 2024 | Award | +3,333 | – | – | 11,890 |
| Dov Klein Director | Jan 1, 2024 | Award | +6,666 | – | – | 63,400 |
| Malcolm Hoenlein Director | Jan 1, 2024 | Award | +3,333 | – | – | 39,042 |
| J. Jay Lobell Director | Jan 1, 2024 | Award | +6,666 | – | – | 115,692 |
| Michael S. Weiss See Remarks, Director, 10% owner | Jan 1, 2024 | Award | +216,465 | – | – | 1,346,985 |
| Eric K. Rowinsky Director | Jan 1, 2024 | Award | +6,666 | – | – | 68,797 |
| Kevin Lorenz Director | Jan 1, 2024 | Award | +3,333 | – | – | 24,304 |
| Lindsay A. Rosenwald Md President, CEO & Chairman, Director, 10% owner | Jan 1, 2024 | Award | +216,465 | – | – | 2,813,905 |
| Jimmie Harvey Director | Jan 1, 2024 | Award | +6,666 | – | – | 69,999 |
| David Jin Chief Financial Officer | Dec 20, 2023 | Award | +140,000 | – | – | 235,916 |
| Lindsay A. Rosenwald Md President, CEO & Chairman, Director, 10% owner | Nov 14, 2023 | Buy | +1,567,515 | $1.70 | $2.66M | 2,597,440 |
| Michael S. Weiss See Remarks, Director | Nov 14, 2023 | Buy | +147,058 | $1.70 | $250.00K | 1,130,520 |
| Lindsay A. Rosenwald Md President, CEO & Chairman, Director, 10% owner | Sep 26, 2023 | Buy | +100,000 | $0.28 | $28.00K | 15,449,091 |
| Lindsay A. Rosenwald Md President, CEO & Chairman, Director, 10% owner | Aug 18, 2023 | Buy | +10,000 | $9.34 | $93.40K | 112,500 |
| Lindsay A. Rosenwald Md President, CEO & Chairman, Director, 10% owner | Aug 17, 2023 | Buy | +10,000 | $11.75 | $117.50K | 102,500 |
| Michael S. Weiss See Remarks, Director, 10% owner | Feb 10, 2023 | Buy | +1,197,604 | $0.84 | $1.01M | 14,752,034 |
| Lindsay A. Rosenwald Md President, CEO & Chairman, Director, 10% owner | Feb 10, 2023 | Buy | +2,395,209 | $0.84 | $2.01M | 15,349,091 |
| David Jin Chief Financial Officer | Feb 10, 2023 | Buy | +35,928 | $0.84 | $30.18K | 1,438,757 |
| J. Jay Lobell Director | Feb 10, 2023 | Buy | +299,401 | $0.84 | $251.50K | 1,635,401 |
| Eric K. Rowinsky Director | Feb 10, 2023 | Buy | +11,976 | $0.84 | $10.06K | 931,976 |
| Lucy Lu Director | Feb 10, 2023 | Buy | +11,976 | $0.84 | $10.06K | 133,379 |
| Dov Klein Director | Jan 1, 2023 | Award | +100,000 | – | – | 851,015 |
| Lindsay A. Rosenwald Md President, CEO & Chairman, Director, 10% owner | Jan 1, 2023 | Award | +1,219,294 | – | – | 12,953,882 |
| Kevin Lorenz Director | Jan 1, 2023 | Award | +50,000 | – | – | 314,572 |
| J. Jay Lobell Director | Jan 1, 2023 | Award | +100,000 | – | – | 1,336,000 |
| Lucy Lu Director | Jan 1, 2023 | Award | +50,000 | – | – | 121,403 |
| Jimmie Harvey Director | Jan 1, 2023 | Award | +100,000 | – | – | 950,000 |
| Malcolm Hoenlein Director | Jan 1, 2023 | Award | +50,000 | – | – | 535,636 |
| Michael S. Weiss See Remarks, Director, 10% owner | Jan 1, 2023 | Award | +1,219,294 | – | – | 13,554,430 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Dov Klein Director | May 17, 2024 | 10,000 | $17.60K | May 20, 2024 | Private Placement |